UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. (Exact name of registrant as specified in its charter) Delaware 45-2973162 (State or other jurisdiction of ...

DarioHealth Corp. (NASDAQ:DRIO) Q2 2020 Results Conference Call August 12, 2020 9:00 AM ET Company Participants Glenn Garmont - IR Erez Raphael - President and CEO Zvi Ben-David - CFO Rick Anderson - General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Scott Schoenhaus - Stephens Ben Haynor - Alliance Global John Vandermosten - Zacks SCR Nathan Weinstein - Aegis Rahul Rakhit - LifeSci Capital Operator Hello, everyone, and thank you for joining today’s DarioHealth Second Quar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |-----------------------------------------------------------------------------------|------------------------------ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------|------------------ ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2019 Earnings Conference Call March 17, 2020 8:30 AM ET Company Participants David Holmes - LifeSci Advisors Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager of North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Ben Haynor - Alliance Global Partners Operator Good morning, ladies and gentleman. And welcome to DarioHealth Fourth Quarter and Full Year 2019 Financial Results C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered: Common Stock, par value $0.0001 per share DRIO The Nasdaq Stock Market LLC Warrants to purchase Common Stock DRIOW The Nasdaq Stock Market LLC FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES ...

DarioHealth Corp. (DRIO) Q3 2019 Earnings Conference Call October 28, 2019 9:00 AM ET Company Participants Erez Raphael - CEO Olivier Jarry - President and CCO Zvi Ben-David - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Ben Haynor - Alliance Global Operator Welcome and thank you for joining DarioHealth Third Quarter Earnings Conference Call. Hosting the call today are Erez Raphael, Chief Executive Officer; Olivier Jarry, President and Chief Commercial Officer; and Zvi Ben-David, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. | --- | --- | |--------------------------------------------------------------------------------------|---- ...

DarioHealth Corp. (NASDAQ:DRIO) Q2 2019 Earnings Conference Call August 13, 2019 9:00 AM ET Company Participants Erez Raphael - CEO Olivier Jarry - President and CCO Zvi Ben-David - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Steven Wardell - Chardan Capital Ben Haynor - Alliance Global Operator Good day, ladies and gentlemen, and welcome to DarioHealth Second Quarter 2019 Earnings Call. Hosting the call today are Erez Raphael, Chief Executive Officer; Olivier Jarry, President a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----------------------------------- ...